Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 7:01 PM ET

Date/Time Source News Release
06/03/2025 08:00 AM EDT PR Newswire Karyopharm to Present at the Jefferies Global Healthcare Conference
06/02/2025 04:05 PM EDT PR Newswire Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/19/2025 07:00 AM EDT PR Newswire Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference
05/14/2025 09:31 AM EDT PR Newswire Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting
05/12/2025 04:05 PM EDT PR Newswire Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hemoglobin Stabilization and Disease Modification
05/08/2025 04:05 PM EDT PR Newswire Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025
05/01/2025 04:05 PM EDT PR Newswire Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/01/2025 04:05 PM EDT PR Newswire Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/03/2025 04:05 PM EST PR Newswire Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/19/2025 07:30 AM EST PR Newswire Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress
Page

Additional News

As of June 12, 2025 • 7:01 PM ET

Date/Time Source News Release
05/26/2025 09:55 AM EDT Zacks Here's Why Karyopharm Therapeutics (KPTI) Is a Great 'Buy the Bottom' Stock Now
05/19/2025 09:55 AM EDT Zacks Does Karyopharm Therapeutics (KPTI) Have the Potential to Rally 521.62% as Wall Street Analysts Expect?
05/13/2025 07:16 AM EDT SeekingAlpha Karyopharm targets $1B peak U.S. revenue in myelofibrosis as Phase 3 SENTRY enrollment nears completion
05/13/2025 07:15 AM EDT SeekingAlpha Karyopharm Therapeutics Inc. (KPTI) Q1 2025 Earnings Call Transcript
05/12/2025 05:25 PM EDT Zacks Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates
05/12/2025 04:38 PM EDT SeekingAlpha Karyopharm Therapeutics GAAP EPS of -$2.77 beats by $1.51, revenue of $30.01M misses by $5.11M
05/12/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - Karyopharm Therapeutics Inc.
05/05/2025 05:10 PM EDT Zacks Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.